Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Superconductor Corporation (AMSC) vs Smith & Nephew plc (SNN) Price & Performance

American Superconductor CorporationTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

American Superconductor Corporation vs Smith & Nephew plc — how do they compare? American Superconductor Corporation trades at $32.51 (market cap $1.56B), while Smith & Nephew plc trades at $29.71 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 8× American Superconductor Corporation's market cap, and Smith & Nephew plc pays a 2.65% dividend while American Superconductor Corporation pays none. Which is the better fit depends on your goals.

AMSCSNN
Market Cap
$1.56B$12.54B
Sector
TechnologyHealth
52-Week High
$66.68$38.70
52-Week Low
$25.95$28.73
Enterprise Value
$1.42B$15.57B
Dividend Yield
2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Superconductor Corporation

AMSC trades at $33.19, up 7.1% today, showing strong momentum despite a bearish technical signal. The company reported record Q1 2026 revenue of $94.1 million, up 30% year-over-year, but missed earnings estimates due to margin pressure. Analyst consensus leans bullish with 53% buy ratings, while technical indicators show resistance at $34 and support at $30.

Outlook remains mixed with strong revenue growth and record backlog providing visibility, but margin compression and aggressive valuation pose risks. The stock offers growth potential in energy infrastructure markets, though investors should monitor execution on profitability targets amid increasing competition.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.

Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Superconductor Corporation

AMSC provides energy technology solutions for smarter and cleaner power grids. It offers wind turbine electronic controls and advanced grid systems that enhance the reliability and efficiency of renewable energy networks.

Read more on AMSC

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN